Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

BUY
$6.7 - $24.21 $8,174 - $29,536
1,220 Added 1906.25%
1,284 $31,000
Q4 2022

Feb 02, 2023

BUY
$4.52 - $10.57 $289 - $676
64 New
64 $1,000
Q2 2022

Aug 03, 2022

SELL
$3.65 - $7.3 $165,710 - $331,420
-45,400 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$3.4 - $7.88 $154,360 - $357,752
45,400 New
45,400 $332,000
Q3 2021

Oct 18, 2021

SELL
$5.66 - $8.33 $28,866 - $42,483
-5,100 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$6.71 - $11.04 $34,221 - $56,303
5,100 New
5,100 $43,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0

About Provention Bio, Inc.


  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.